ArticleCancer epidemiology2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.
Joseph M Unger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it